Author Correction: Evolution of HER2-low expression from primary to recurrent breast cancer

Código QR

Author Correction: Evolution of HER2-low expression from primary to recurrent breast cancer

Guardado en:

Detalles Bibliográficos
Autores principales:	Federica Miglietta, Gaia Griguolo, Michele Bottosso, Tommaso Giarratano, Marcello Lo Mele, Matteo Fassan, Matilde Cacciatore, Elisa Genovesi, Debora De Bartolo, Grazia Vernaci, Ottavia Amato, PierFranco Conte, Valentina Guarneri, Maria Vittoria Dieci
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/5a209eb810624fa3b79e6ac0b52cc517
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Impact of estrogen receptor levels on outcome in non-metastatic triple negative breast cancer patients treated with neoadjuvant/adjuvant chemotherapy
por: Maria Vittoria Dieci, et al.
Publicado: (2021)

Immune microenvironment and intrinsic subtyping in hormone receptor-positive/HER2-negative breast cancer
por: Gaia Griguolo, et al.
Publicado: (2021)

Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade
por: Fara Brasó-Maristany, et al.
Publicado: (2020)

Immune microenvironment characterisation and dynamics during anti-HER2-based neoadjuvant treatment in HER2-positive breast cancer
por: G. Griguolo, et al.
Publicado: (2021)

The role of HER2 and HER3 in HER2-amplified cancers beyond breast cancers
por: Avisek Majumder, et al.
Publicado: (2021)

Preclinical therapy of disseminated HER-2⁺ ovarian and breast carcinomas with a HER-2-retargeted oncolytic herpesvirus.
por: Patrizia Nanni, et al.
Publicado: (2013)

Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progression
por: Veronica Giusti, et al.
Publicado: (2021)

Remembering Sally Engle Merry: Her scholarship and her legacy
por: Anne Griffiths
Publicado: (2021)

Assessment of HER2 testing patterns, HER2+ disease, and the utilization of HER2-directed therapy in early breast cancer
por: Stenehjem DD, et al.
Publicado: (2014)

The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial
por: Laura Pizzuti, et al.
Publicado: (2021)

ZOË BOCCABELLA’S CALABRIAN CHAPTER IN MEZZA ITALIANA AS A SYMBOLIC ELIMINATION OF SOUTHERNESS FROM HER OWN DIASPORIC SELF
por: Teresa Di Somma, et al.
Publicado: (2017)

An Islam of Her Own
por: Fatima Seedat
Publicado: (2013)

Her majesty the transaction
por: Gaćeša Radmila
Publicado: (2021)

In her own time
por: Flora Jung
Publicado: (2018)

Her voice lingers on and her memory is strategic: effects of gender on directed forgetting.
por: Hwajin Yang, et al.
Publicado: (2013)

May Her Likes Be Multiplied
por: Nancy L. Stockdale
Publicado: (2002)

Dual HER2 blockade in the neoadjuvant and adjuvant treatment of HER2-positive breast cancer
por: Advani P, et al.
Publicado: (2015)

Robust and accurate digital measurement for HER2 amplification in HER2 equivocal breast cancer diagnosis
por: Yuefeng Wang, et al.
Publicado: (2017)

Mismatch repair deficiency predicts response to HER2 blockade in HER2-negative breast cancer
por: Nindo B. Punturi, et al.
Publicado: (2021)

Synthetic lethality between HER2 and transaldolase in intrinsically resistant HER2-positive breast cancers
por: Yi Ding, et al.
Publicado: (2018)

The translator and his/her language/culture
por: Reinhold Utri
Publicado: (2021)

Narrative of Her Life: Mary Jemison
Publicado: (2017)

Rara and Her Bedtime Story Journey
por: Rudi Suherman
Publicado: (2020)

Utility of Serum HER-2/ neu in Prediction of Tissue HER-2 /neu Status of Primary Breast Cancer
por: Maral Mokhtari, et al.
Publicado: (2021)

HER2 + breast cancers evade anti-HER2 therapy via a switch in driver pathway
por: Alison E. Smith, et al.
Publicado: (2021)

La escolástica española y la génesis de la filosofía latinoamericana. Alonso Briceño metafísica e individualidad /
por: Cacciatore, Giuseppe
Publicado: (2006)

Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancer
por: Yunhua Liu, et al.
Publicado: (2018)

Spontaneous epithelial-mesenchymal transition and resistance to HER-2-targeted therapies in HER-2-positive luminal breast cancer.
por: David Lesniak, et al.
Publicado: (2013)

THE EFFECT OF THE DOE WEIGHT ON HER REPRODUCTIVE EFFICIENY
por: Mohammad Ebrahim Ahmed, et al.
Publicado: (2021)

REVIEW: Paying with her life for telling it like it is
por: Seumas Phelan
Publicado: (2004)

In her own words: Melanesian women in media
por: Faith Valencia-Forrester, et al.
Publicado: (2020)

Quantification of EGFR-HER2 Heterodimers in HER2-Overexpressing Breast Cancer Cells Using Liquid-Phase Electron Microscopy
por: Diana B. Peckys, et al.
Publicado: (2021)

HER2 phosphorylation is maintained by a PKB negative feedback loop in response to anti-HER2 herceptin in breast cancer.
por: Merel Gijsen, et al.
Publicado: (2010)

Simulation of a flash-flood event over the Adriatic Sea with a high-resolution atmosphere–ocean–wave coupled system
por: Antonio Ricchi, et al.
Publicado: (2021)

TROUGH HER EYES. THE ADVENTURES OF MARGARET MCKELVY BIRD
por: Martinic,Mateo
Publicado: (2017)

Letter to her Husband, Absent Upon Publick Employment
Publicado: (2017)

HER2 breast cancer therapies: a review
por: Conleth G Murphy, et al.
Publicado: (2009)

Bevacizumab in the treatment of HER2-negative breast cancer
por: Vito Lorusso
Publicado: (2008)

Financial recovery as bankruptcy proceedings or result of her conduct
por: O. YU. Rudakova, et al.
Publicado: (2017)

Fundamentos de derecho argentino libro de casos /
por: Genovesi, Luis Mariano
Publicado: (2010)